301 related articles for article (PubMed ID: 19776172)
1. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.
Wang XX; Jiang T; Shen Y; Adorini L; Pruzanski M; Gonzalez FJ; Scherzer P; Lewis L; Miyazaki-Anzai S; Levi M
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1587-96. PubMed ID: 19776172
[TBL] [Abstract][Full Text] [Related]
2. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats.
Hu Z; Ren L; Wang C; Liu B; Song G
Kidney Blood Press Res; 2012; 36(1):85-97. PubMed ID: 22948014
[TBL] [Abstract][Full Text] [Related]
3. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
[TBL] [Abstract][Full Text] [Related]
4. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
[TBL] [Abstract][Full Text] [Related]
6. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism.
Wang XX; Jiang T; Shen Y; Santamaria H; Solis N; Arbeeny C; Levi M
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F801-10. PubMed ID: 21209008
[TBL] [Abstract][Full Text] [Related]
8. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.
Jiang T; Liebman SE; Lucia MS; Li J; Levi M
Kidney Int; 2005 Dec; 68(6):2608-20. PubMed ID: 16316337
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.
Gai Z; Gui T; Hiller C; Kullak-Ublick GA
J Biol Chem; 2016 Jan; 291(5):2397-411. PubMed ID: 26655953
[TBL] [Abstract][Full Text] [Related]
10. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
Wang Z; Jiang T; Li J; Proctor G; McManaman JL; Lucia S; Chua S; Levi M
Diabetes; 2005 Aug; 54(8):2328-35. PubMed ID: 16046298
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury.
Zhu JB; Xu S; Li J; Song J; Luo B; Song YP; Zhang ZH; Chen YH; Xie DD; Yu DX; Xu DX
Eur J Pharmacol; 2018 Nov; 838():60-68. PubMed ID: 30196109
[TBL] [Abstract][Full Text] [Related]
12. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
Wang XX; Luo Y; Wang D; Adorini L; Pruzanski M; Dobrinskikh E; Levi M
J Biol Chem; 2017 Jul; 292(29):12018-12024. PubMed ID: 28596381
[TBL] [Abstract][Full Text] [Related]
13. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway.
Jiang T; Wang Z; Proctor G; Moskowitz S; Liebman SE; Rogers T; Lucia MS; Li J; Levi M
J Biol Chem; 2005 Sep; 280(37):32317-25. PubMed ID: 16046411
[TBL] [Abstract][Full Text] [Related]
14. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.
Jiang T; Liebman SE; Lucia MS; Phillips CL; Levi M
J Am Soc Nephrol; 2005 Aug; 16(8):2385-94. PubMed ID: 15944339
[TBL] [Abstract][Full Text] [Related]
15. Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis.
Song D; Zhang A; Hu X; Zeng M; Zhou H
Phytomedicine; 2023 Jul; 116():154861. PubMed ID: 37167823
[TBL] [Abstract][Full Text] [Related]
16. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
[TBL] [Abstract][Full Text] [Related]
17. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease.
Miyazaki-Anzai S; Levi M; Kratzer A; Ting TC; Lewis LB; Miyazaki M
Circ Res; 2010 Jun; 106(12):1807-17. PubMed ID: 20431060
[TBL] [Abstract][Full Text] [Related]
20. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome.
Tovar AR; Murguía F; Cruz C; Hernández-Pando R; Aguilar-Salinas CA; Pedraza-Chaverri J; Correa-Rotter R; Torres N
J Nutr; 2002 Sep; 132(9):2562-9. PubMed ID: 12221209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
